Beam Therapeutics (BEAM) Treasury Shares (2019 - 2026)

Beam Therapeutics (BEAM) has 8 years of Treasury Shares data on file, last reported at $3.3 million in Q1 2026.

• On a quarterly basis, Treasury Shares rose 8.85% year-over-year to $3.3 million in Q1 2026; TTM through Mar 2026 was $3.3 million, a 8.85% increase from a year earlier, with the FY2025 full-year figure at $2.5 million, down 1.28% from the prior year.
• Treasury Shares for Q1 2026 stood at $3.3 million, up from $2.5 million in the prior quarter.
• Over the last five years, Treasury Shares for BEAM reached as high as $3.4 million in Q1 2024 and fell as low as $1.5 million in Q1 2022.
• Historically, Treasury Shares has averaged $2.5 million across 5 years, with a median of $2.6 million in 2024.
• Across the five-year window, Treasury Shares jumped 72.92% in 2023 and fell 14.09% in 2025, its largest moves.
• Year by year, Treasury Shares stood at $1.7 million in 2022, then soared by 72.92% to $2.9 million in 2023, then declined by 11.97% to $2.6 million in 2024, then dropped by 1.28% to $2.5 million in 2025, then surged by 31.4% to $3.3 million in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $3.3 million in Q1 2026, $2.5 million in Q4 2025, and $2.8 million in Q3 2025.